Metformin limits osteoarthritis development and progression through activation of AMPK signalling
Jun Li(Jiangnan University), Di Chen(China Rehabilitation Research Center), Guozhi Xiao(Southern University of Science and Technology), Cong Xing(Tianjin Medical University General Hospital), Shiqing Feng(Tianjin Medical University General Hospital), Lan Zhao(Rush University Medical Center), Wei‐Xiao Liu(Tianjin Medical University General Hospital), Bin Zhang(Guangzhou University of Chinese Medicine), Dan Yi(Rush University Medical Center), Jian Huang(University of Rochester Medical Center), Tingyu Wang(Shanghai Jiao Tong University), Chun‐do Oh(Rush University Medical Center), Guangzhi Ning(Tianjin Medical University General Hospital), Ke Lu(Shenzhen Institute of Information Technology), Haobo Pan(Shenzhen Institutes of Advanced Technology), Ru Liu‐Bryan(University of California San Diego)
Cited by 301
Related Papers
Osteoarthritis: toward a comprehensive understanding of pathological mechanism
|Bone Research|2017|1.2k
Osteoarthritis: pathogenic signaling pathways and therapeutic targets
|Signal Transduction and Targeted Therapy|2023|1k
Implant-derived magnesium induces local neuronal production of CGRP to improve bone-fracture healing in rats
|Nature Medicine|2016|1k
MicroRNA-204 Regulates Runx2 Protein Expression and Mesenchymal Progenitor Cell Differentiation
|Stem Cells|2009|611
Clinical Features of the Initial Cases of 2009 Pandemic Influenza A (H1N1) Virus Infection in China
|New England Journal of Medicine|2009|603